Both Dilantin and Pennsaid offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Dilantin and Pennsaid have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Dilantin has a lower risk of dependency, making it a safer option for patients concerned about addiction.

Pennsaid offers greater flexibility with different delivery forms, making it suitable for patients with specific preferences or medical needs.

Dilantin has fewer contraindications, making it suitable for a broader range of patients, including those with comorbidities.

Both drugs offer advantages depending on treatment goals. Dilantin is great for fast relief, while Pennsaid is better for long-term management. The choice depends on the patient’s specific needs.